AI 채팅

The Cooper Companies, Inc.

COO · NasdaqGS · USD

54.61 +1.34 (2.52%)

종가 기준: Sep 16, 2026, 3:59 PM

54.65 +0.07%

애프터마켓: 7:53 PM

시가총액
$10.38B
거래량
5.31M

The Cooper Companies, Inc.(COO) 주가, 분석 및 데이터

내재가치

내재 가치 로딩 중…

애널리스트 전망

주가 전망 →

목표주가

$58.00 – $75.00

중앙값 $65.50 · 19.94% 상승 여력

12개월 목표가 · 애널리스트 14명

애널리스트 컨센서스: 매수

간격:1D
캔들과 신호 불러오는 중…

재무 실적

재무 정보 보기 →

불러오는 중...

최근 실적

발표치예상 대비전년 대비
매출$1.07Bn/a+0.56%
EPS$1.15+$0.03+4.55%

다음 실적 발표

정규장 중입니다.

예상치 · 업그레이드 →

실적 상세 보기 →

지표

매수호가
54.44
순이익 (ttm)
570M
0.82
2.98
18.33
11.63
P/B (ttm)
1.25
P/S (ttm)
2.45
실적 발표일
Dec 10, 2026
매도호가
54.53
거래량
5,314,057
평균 거래량 (20일)
2,765,119
시가
54.37
전일 종가
53.27
일중 범위
53.92 - 55.12
52주 범위
51.01 - 89.83
목표주가
65.5 (19.94%)
배당
n/a
배당락일
Jul 26, 2023

The Cooper Companies, Inc. 소개

기업 정보 보기 →
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California. Medical Instruments & Supplies · Healthcare

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

섹터 Healthcare
IPO 일자 Jan 21, 1983
직원 수 15,000
상장 거래소 NasdaqGS
티커 COO